Davis Polk & Wardwell advised the representative of the initial purchasers on the offering. Vishay Intertechnology, Inc. (NYSE: VSH) announced it has completed its offering of $750 million aggregate...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering. Coherus BioSciences, Inc. (“Coherus”, Nasdaq:...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the underwriters in the offering. Allakos Inc. announced its offering of 29,882,000 shares of common stock, for total gross proceeds of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Allakos, while Davis Polk advised the underwriter, Cowen, in the offering. Allakos Inc. announced it may issue and sell shares of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Acutus Medical on the deal. Acutus Medical, Inc. announced the sale of its left-heart access portfolio products to Medtronic, for an upfront payment of...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell, Ropes & Gray and Skadden, Arps, Slate, Meagher & Flom advised HP on the deal. Wilson Sonsini Goodrich & Rosati represented Poly....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
You must be a Standard 1 Year member to access this content.
